Impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer

被引：0
|
作者：
Fowble, B.
Fein, D.A.
Hanlon, A.L.
Eisenberg, B.L.
Hoffman, J.P.
Sigurdson, E.R.
Daly, M.B
Goldstein, L.J.
机构：
来源：
International Journal of Radiation Oncology, Biology, Physics | 1996年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
    Alvarado, Michael D.
    Prasad, Che
    Rothney, Megan
    Cherbavaz, Diana B.
    Sing, Amy P.
    Baehner, Frederick L.
    Svedman, Christer
    Markopoulos, Christos J.
    ADVANCES IN THERAPY, 2015, 32 (12) : 1237 - 1247
  • [42] Clinical outcomes and Oncotype DX Breast Recurrence Score (R) in early-stage BRCA-associated hormone receptor-positive breast cancer
    Layman, Rachel M.
    Lin, Heather
    Barrera, Angelica M. Gutierrez
    Karuturi, Meghan S.
    Yam, Clinton
    Arun, Banu K.
    CANCER MEDICINE, 2022, 11 (06): : 1474 - 1483
  • [43] The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
    Ahn, Sung Gwe
    Lee, Hak Min
    Cho, Sang-Hoon
    Bae, Suk Jin
    Lee, Seung Ah
    Hwang, Seung Hyun
    Jeong, Joon
    Lee, Hy-De
    PLOS ONE, 2013, 8 (05):
  • [44] Modelling the spatial heterogeneity of CD45-positive tumor infiltrating lymphocytes in early-stage, estrogen receptor-positive breast cancer
    Kinsella, Zak
    Blumel, Anna
    Lucas, Mairi
    Lindner, Andreas
    Gonzalez, Claudia A.
    Rahman, Arman
    Fay, Joanna
    O'Grady, Tony
    Murphy, Verena
    Crown, John
    Kelly, Cathy
    Gallagher, William
    O'Connor, Darran
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Use of Tamoxifen With Postsurgical Irradiation May Improve Survival in Estrogen and Progesterone Receptor-Positive Male Breast Cancer
    Fogh, Shannon
    Hirsch, Ariel E.
    Langmead, Jon P.
    Goldberg, Saveli I.
    Rosenberg, Carol L.
    Taghian, Alphonse G.
    Powell, Simon N.
    Kachnic, Lisa A.
    CLINICAL BREAST CANCER, 2011, 11 (01) : 39 - 45
  • [46] The Effect of Oncotype DX Recurrence Score on Treatment Recommendations for Patients with Estrogen Receptor-Positive Early Stage Breast Cancer and Correlation with Estimation of Recurrence Risk by Breast Cancer Specialists
    Joh, Jennifer E.
    Esposito, Nicole N.
    Kiluk, John V.
    Laronga, Christine
    Lee, M. Catherine
    Loftus, Loretta
    Soliman, Hatem
    Boughey, Judy C.
    Reynolds, Carol
    Lawton, Thomas J.
    Acs, Peter I.
    Gordan, Lucio
    Acs, Geza
    ONCOLOGIST, 2011, 16 (11): : 1520 - 1526
  • [47] Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
    Bostner, Josefine
    Alayev, Anya
    Berman, Adi Y.
    Fornander, Tommy
    Nordenskjold, Bo
    Holz, Marina K.
    Stal, Olle
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 17 - 27
  • [48] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
    Fisher, B
    Dignam, J
    Wolmark, N
    DeCillis, A
    Emir, B
    Wickerham, DL
    Bryant, J
    Dimitrov, NV
    Abramson, N
    Atkins, JN
    Shibata, H
    Deschenes, L
    Margolese, RG
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22): : 1673 - 1682
  • [49] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
    Atkins, CD
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (06) : 468 - 468
  • [50] Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
    Owusu, Cynthia
    Buist, Diana S. M.
    Field, Terry S.
    Lash, Timothy L.
    Thwin, Soe Soe
    Geiger, Ann M.
    Quinn, Virginia P.
    Frost, Floyd
    Prout, Marianne
    Yood, Marianne Ulcickas
    Wei, Feifei
    Silliman, Rebecca A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 549 - 555
12345